Browsing: Emerging

Migraine is a primary headache disorder affecting approximately 14% of the global population. For individuals affected, however, labeling migraine as…

This Symposium will be hosted live and available on-demandMay 19-20, 2026 11:00 AM – 3:00 PM ETInfectious disease researchers employ diverse…

This Symposium will be hosted live and available on-demandMarch 17-18, 202611:00 AM – 3:00 PM ETCancer treatment is rapidly evolving…

Our host, Sandra Saville IPA’s Director of Education and Communication, sits down with Dr. John Deaton, Vice President of Science…

Sponsored content brought to you by Nucleic acids are emerging as a third generation of pharmaceuticals following the clinical accomplishments…

Schizophrenia (SCZ) is a disabling psychiatric disorder that places a heavy burden on patients, families, and health systems. Despite available…

View eBook The landscape of proteomics technologies has traditionally been defined by trade offs between coverage—the ability to detect many…

Prostate cancer (PC)—a major global health challenge— presents a wide spectrum of outcomes, from slow-growing tumors to aggressive metastatic disease.…

Within the field of gastroenterology, Clostridioides difficile infection is recognized as a major problem globally. Previously called pseudomembranous colitis, the…

As mRNA-based therapeutics move beyond early vaccine successes to encompass diverse modalities, the expectations for manufacturers to deliver products with…